Free Trial

Northwest Biotherapeutics (NWBO) SEC Filings & 10K Form

Northwest Biotherapeutics logo
$0.24 +0.00 (+0.75%)
As of 03:59 PM Eastern

Recent Northwest Biotherapeutics SEC Filings

DateFilerForm TypeView
03/31/2025
4:23 PM
Northwest Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/26/2024
4:07 PM
Northwest Biotherapeutics (Filer)
Form 424B5
12/26/2024
3:29 PM
Northwest Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:24 PM
Northwest Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:30 PM
BOYNTON ALTON L (Reporting)
Northwest Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
9:42 AM
Northwest Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:49 PM
MALIK NAVID (Reporting)
Northwest Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:NWBO) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners